v3.24.4
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock to be Issued [Member]
Balance at Dec. 31, 2021 $ 12 $ 12,063,940 $ (13,844,512) $ (1,764,220) $ 16,340
Balance, shares at Dec. 31, 2021 1,164,039       1,213  
Common stock issued for restricted stock units
Common stock issued for restricted stock units, shares 3,500          
Stock-based compensation 237,547 237,547
Net loss (4,996,069) (4,996,069)
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated 1,199,916 $ 1,199,916
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated, shares 36,876     105    
Warrants issued for financing costs, net of issuance fees of $8,727 14,662 $ 14,662
Common stock issued for cash upon initial public offering and exercise of warrants, net of issuance costs, as restated $ 4 9,951,352 $ 9,951,356
Common stock issued for cash upon initial public offering and exercise of warrants, net of issuance costs, as restated, shares 352,443     3,750    
Common stock issued for conversion of accrued interest, as restated 16,340 (16,340)
Common stock issued for conversion of accrued interest, as restated, shares 105          
Common stock issued for exercise of warrants with settlement of notes payable, as restated $ 1 2,153,123 2,153,124
Common stock issued for exercise of warrants with settlement of notes payable, as restated, shares 66,250          
Common stock issued upon exercise of warrants, as restated
Common stock issued upon exercise of warrants, as restated, shares 22,535          
Dividends on Series A convertible preferred stock, as restated (402,064) (402,064)
Deemed dividend on extinguishment of Series A Preferred Stock
Deemed dividend on modification of equity-classified warrants
Deemed contribution on conversion of preferred stock and settlement of preferred stock dividend
Common shares issued for dividends on and conversion of Series A convertible preferred stock, as restated 402,064 402,064
Common shares issued for dividends on and conversion of Series A convertible preferred stock, as restated, shares 54,666       (1,213)  
Reclassification of fair value of warrant liabilities to equity, as restated 881,553 881,553
Balance at Dec. 31, 2022 $ 17 26,518,433 (18,840,581) 7,677,869
Balance, shares at Dec. 31, 2022 1,700,414        
Common stock issued for conversion of accrued interest and principal 104,547 104,547    
Common stock issued for conversion of accrued interest and principal, shares 6,375          
Stock-based compensation 8,333 8,333    
Net loss (975,097) (975,097)    
Warrants issued for financing costs, net of issuance fees of $8,727 90,816 90,816    
Balance at Mar. 31, 2023 $ 17 26,722,129 (19,815,678) 6,906,468    
Balance, shares at Mar. 31, 2023 1,706,789          
Balance at Dec. 31, 2022 $ 17 26,518,433 (18,840,581) 7,677,869
Balance, shares at Dec. 31, 2022 1,700,414        
Common stock issued for restricted stock units, shares 1,876          
Net loss       (4,952,223)    
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated, shares 297,625          
Balance at Sep. 30, 2023 $ 20 29,402,533 (23,792,804) 5,609,749    
Balance, shares at Sep. 30, 2023 1,999,915          
Balance at Dec. 31, 2022 $ 17 26,518,433 (18,840,581) 7,677,869
Balance, shares at Dec. 31, 2022 1,700,414        
Common stock issued for conversion of accrued interest and principal $ 3 2,697,846 2,697,849
Common stock issued for conversion of accrued interest and principal, shares 297,625          
Common stock issued for restricted stock units
Common stock issued for restricted stock units, shares 10,650          
Stock-based compensation 181,960 181,960
Net loss (6,592,723) $ (6,592,723)
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated, shares       297,625    
Warrants issued for financing costs, net of issuance fees of $8,727 90,816 $ 90,816
Common stock issued for cash upon initial public offering and exercise of warrants, net of issuance costs, as restated, shares 297,625          
Balance at Dec. 31, 2023 $ 20 29,489,055 (25,433,304) 4,055,771
Balance, shares at Dec. 31, 2023 2,008,689        
Balance at Mar. 31, 2023 $ 17 26,722,129 (19,815,678) 6,906,468    
Balance, shares at Mar. 31, 2023 1,706,789          
Common stock issued for conversion of accrued interest and principal $ 2 2,163,990 2,163,992    
Common stock issued for conversion of accrued interest and principal, shares 228,489          
Stock-based compensation 49,522 49,522    
Net loss (2,184,372) (2,184,372)    
Balance at Jun. 30, 2023 $ 19 28,935,641 (22,000,050) 6,935,610    
Balance, shares at Jun. 30, 2023 1,935,278          
Common stock issued for restricted stock units    
Common stock issued for restricted stock units, shares 1,876          
Stock-based compensation 37,583 37,583    
Net loss (1,792,754) (1,792,754)    
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated $ 1 429,309 429,310    
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated, shares 62,761          
Balance at Sep. 30, 2023 $ 20 29,402,533 (23,792,804) 5,609,749    
Balance, shares at Sep. 30, 2023 1,999,915          
Balance at Dec. 31, 2023 $ 20 29,489,055 (25,433,304) 4,055,771
Balance, shares at Dec. 31, 2023 2,008,689        
Common stock issued for conversion of accrued interest and principal $ 1 325,297 325,298    
Common stock issued for conversion of accrued interest and principal, shares 78,197          
Common stock issued for restricted stock units    
Common stock issued for restricted stock units, shares 15,625          
Stock-based compensation 111,449 111,449    
Net loss (1,731,031) (1,731,031)    
Balance at Mar. 31, 2024 $ 21 29,925,801 (27,164,335) 2,761,487    
Balance, shares at Mar. 31, 2024 2,102,511          
Balance at Dec. 31, 2023 $ 20 29,489,055 (25,433,304) 4,055,771
Balance, shares at Dec. 31, 2023 2,008,689        
Common stock issued for restricted stock units, shares 24,349          
Net loss       (7,546,328)    
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated, shares 797,345          
Common stock issued for reverse stock split fractional share round up, shares 115,716          
Balance at Sep. 30, 2024 $ 29 31,664,226 (32,979,632) (1,315,377)    
Balance, shares at Sep. 30, 2024 2,946,099          
Balance at Mar. 31, 2024 $ 21 29,925,801 (27,164,335) 2,761,487    
Balance, shares at Mar. 31, 2024 2,102,511          
Common stock issued for restricted stock units    
Common stock issued for restricted stock units, shares 3,722          
Stock-based compensation 71,162 71,162    
Net loss (2,031,215) (2,031,215)    
Balance at Jun. 30, 2024 $ 21 29,996,963 (29,195,550) 801,434    
Balance, shares at Jun. 30, 2024 2,106,233          
Common stock issued for restricted stock units    
Common stock issued for restricted stock units, shares 5,002          
Stock-based compensation 45,275 45,275    
Net loss (3,784,082) (3,784,082)    
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated $ 7 1,621,989 1,621,996    
Common stock issued upon conversion of convertible debt and exercise of related warrants, as restated, shares 719,148          
Common stock issued for reverse stock split fractional share round up $ 1 (1)    
Common stock issued for reverse stock split fractional share round up, shares 115,716          
Balance at Sep. 30, 2024 $ 29 $ 31,664,226 $ (32,979,632) $ (1,315,377)    
Balance, shares at Sep. 30, 2024 2,946,099